Ask Warren

Inbiogen

101140 · KOSPI · ₩101140 · 인바이오젠

₩4,605 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩6.3B₩7B₩6.2B₩11B₩10B
Cost of sales₩6.6B₩6.4B₩4.9B₩9.1B₩8.5B
Gross profit−₩347M₩660M₩1.3B₩2.3B₩2B
Operating income−₩4.3B−₩6.1B−₩6.2B−₩6.3B−₩7.9B
Net income−₩1.4B₩16B₩11B−₩117B₩94B
Net income to shareholders−₩1.4B₩16B₩11B−₩117B₩94B

Balance sheet

20252024202320222021
Total assets₩160B₩163B₩146B₩144B₩274B
Current assets₩5.3B₩9.3B₩11B₩17B₩32B
Cash and equivalents₩902M₩5.7B₩6.1B₩9.3B₩23B
Total liabilities₩2.3B₩2.9B₩2.6B₩37B₩96B
Current liabilities₩1.9B₩2.1B₩2.1B₩36B₩78B
Borrowings———₩934M₩12B
Total equity₩158B₩160B₩143B₩107B₩178B
Shareholders' equity₩158B₩160B₩143B₩107B₩178B

Cash flow

20252024202320222021
Cash from operations−₩5.6B−₩33M−₩1.1B−₩12B−₩7.1B
Capital spending₩43M₩24M₩26M₩131M₩2.4B
Free cash flow−₩5.6B−₩57M−₩1.1B−₩12B−₩9.4B

Consolidated where available. Amounts in won.

Also known as: Inbiogen / 인바이오젠 / 101140 / KRX:101140

Source: KRX statistical information